The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADTALEM GLOBAL ED INC | COM | 00737L103 | 99,684 | 1,691 | SH | SOLE | 1,691 | 0 | 0 | ||
VANGUARD INDEX FDS | S&P 500 ETF SHS | 922908363 | 7,106,736 | 16,270 | SH | SOLE | 16,270 | 0 | 0 | ||
VANGUARD BD INDEX FDS TOTAL BND MRKT | TOTAL BND MRKT | 921937835 | 51,962,192 | 706,488 | SH | SOLE | 706,488 | 0 | 0 | ||
VANGUARD INTL EQUITY INDEX F | TT WRLD ST ETF | 922042742 | 8,357,251 | 81,233 | SH | SOLE | 81,233 | 0 | 0 | ||
PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 87,716 | 48,731 | SH | SOLE | 48,731 | 0 | 0 | ||
VANGUARD INDEX FDS | S&P 500 ETF SHS | 922908363 | 705,432 | 1,615 | SH | SOLE | 1,615 | 0 | 0 | ||
OVINTIV INC | COM | 69047Q102 | 439,200 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
JPMORGAN ALERIAN MLP INDEX ETN | FUND | 46625H365 | 1,719,433 | 67,801 | SH | SOLE | 67,801 | 0 | 0 | ||
NKGEN BIOTECH INC | COM | 65488A101 | 1,512,500 | 550,000 | SH | SOLE | 550,000 | 0 | 0 |